Therefore, phosphorylation at different sites regulated by kinases affects mitochondrial recruitment of DRP1, indicating different functional and morphological effects, and the regulation of DRP1 phosphorylation at different sites is a potential therapeutic target against the stroke injury. This evidence concerns the gene DNM1L and Stroke.